Retractable Needle Safety Syringes Market Outlook (2023 to 2033)

The global retractable needle safety syringes market is likely to reach a valuation of US$ 5,846.6 million in 2023 and is projected to expand at a steady CAGR of 4.1% between 2023 and 2033, totaling around US$ 8,770 million by 2033. The rising prevalence of various diseases across the world is a key factor driving demand for retractable needle safety syringes.

Manual retractable safety syringe is expected to continue to lead the global retractable needle safety syringes market based on product, accounting for around 62.13% share in 2022.

In 2022, the market value for retractable needle safety syringes market held more than 2.6% of the overall global medical supplies market which stood at around US$ 215.0 billion.

The demand for retractable needle safety syringes is increasing constantly due to the rising incidence of needle stick injuries. All parenteral pharmaceutical products have to be injected using drug delivery devices. Also, syringes are the most commonly used devices. Injecting through needle-based devices presents a considerable risk of needle stick injury. For instance,

The Centers for Disease Control and Prevention reports that over 385,000 needle stick injuries affect healthcare professionals each year in the United States. In particular, blood-borne viruses are spreading through these needle stick injuries. Hepatitis B and hepatitis C are of concern, as well as the human immunodeficiency virus (HIV), which causes AIDS (acquired immune deficiency syndrome).

The rising number of needle stick injuries has resulted in a shift toward regulatory authorities recommending the use of protected needles and retractable needle safety syringes, which is helping to boost the global retractable needle safety syringes industry.

Companies operating in the retractable needle safety syringes industry are actively seeking to strengthen their position through product launches, approvals, collaborations, and partnerships with established as well as emerging market players. For instance,

  • In June 2022, Becton, Dickinson, and Company, a leading international provider of medical technology announced a partnership with Mayo Clinic to gain access to de-identified data of patients from the Mayo Clinic platform-Discover.
Attributes Statistics
Retractable Needle Safety Syringes Market Base Value (2023) US$ 5,846.6 million
Projected Market Size (2033) US$ 8,770 million
Value-based CAGR (2023 to 2033) 4.1%
Market Share of Top 5 Countries 53.9%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Retractable Needle Safety Syringes From 2018 to 2022 Vs Market Outlook for 2023 to 2033

The global sales of retractable needle safety syringes are anticipated to rise at a CAGR of 4.1% between 2023 and 2033, owing to the increased adoption of advanced retractable needle safety syringes across healthcare facilities.

There has been an increasing adoption of manual retractable safety syringes, thereby making it the leading segment with the advantages of manual retractable safety syringes over other available syringes found in the market. Further, the demand for retractable needle safety syringes is rising due to a surge in diseases like diabetes, cancer, and hepatitis, growing health awareness among people, and innovations in retractable needle safety syringes.

Safety needles improve user convenience and practicability while lowering the risk of infection and cost. The majority of healthcare professionals prefer safety needle technology to conventional devices due to beneficial factors like accuracy, operation time, and fast usage design.

Retractable safety syringes increase the patient’s power in making healthcare decisions, which is eventually helping to boost the global market for retractable needle safety syringes.

In addition, many people use sterile needles and syringes for each injection for the administration of drugs.

Sterile needles prevent the spread of diseases like HIV and viral hepatitis among other infections. People who inject drugs have access to sterile needles and syringes through pharmacies and syringe services programs (SSPs) in several areas.

Access to syringes is also possible through a doctor’s prescription and through other healthcare services. SSPs are based on community programs that provide access to sterile syringes and needles at no cost and help in facilitating the safe disposal of used needles and syringes.

The increasing number of needle and syringe programs aimed at reducing the possibility of disease transmission is one of the primary factors contributing to the growth of the global retractable needle safety syringe industry.

What are the Key Trends Driving the Retractable Needle Safety Syringes Market?

Introduction of Stringent Regulations Pushing Demand for Retractable Needle Safety Syringes

The global sales of retractable needle safety syringes are expected to rise due to increasing government initiatives and regulations to maximize the use of safe syringes. Over the years, the rising incidence of needle stick injuries and the high mortality rate associated with these injuries have prompted governments and regulatory bodies to take various steps. To reduce needle stick injuries and prevent needle reusing, countries like Germany, the United States, and other ASEAN have passed legislation requiring the use of safe syringes.

Thanks to the introduction of this regulation, safety syringes such as retractable needle safety syringes are now used frequently compared to traditional syringes, which has resulted in a significant increase in demand in the market for retractable needle safety syringes.

Retractable needle safety syringes have an internal safety device and either a detachable or a fixed needle. Further, they help in avoiding accidental needle stick injuries among healthcare professionals and spreading blood-borne diseases.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining the Demand for Retractable Needle Safety Syringes?

The presence of alternative drug delivery solutions like needle-free injection technology is becoming a key factor restraining the growth of the retractable needle safety syringes industry.

The “needle-free injection technology" (NFIT) comprises a wide variety of drug delivery methods that administer medication through the skin using forces like Lorentz, shock waves, pressure from gases, or electrophoresis, all of which potentially reduce the need for retractable as well as hypodermic needles.

Country-wise Insights

What Makes the United States a Significant Market for Retractable Needle Safety Syringes?

A Notable Rise in Needle Stick Injuries Pushing Demand for Retractable Needle Safety Syringes in the United States

Country The United States
Market Share % (2022) 27.2%

The United States held a total share of 81.4% of North America’s retractable needle safety syringes market in 2022 and is poised to exhibit steady growth during the forecast period. Growth in the United States retractable needle safety syringes market is driven by rising cases of needle stick injuries, increasing adoption of advanced technologies, and the presence of a well-established healthcare industry. Also, in recent years, there has been a sharp rise in needle stick injuries across the United States. For instance,

  • The Centers for Disease Control and Prevention reports that over 385,000 needle stick injuries affect healthcare professionals each year in the United States. This is positively impacting the retractable needle safety syringes industry in the country.

Rising investments and government support in conducting research in various sectors are expected to attract huge attention to the retractable needle safety syringes market in the United States.

Why is Germany Considered a Dominant Market for Retractable Needle Safety Syringes in Europe?

Increasing Prevalence of Chronic Diseases Propelling Retractable Needle Safety Syringes Sales in Germany

Country Germany
Market Share % (2022) 4.4%

As per FMI, the retractable needle safety syringes industry in Germany is set to exhibit a CAGR of 4.1% during the forecast period. Demand for retractable needle safety syringes in Germany is driven by the increasing prevalence of chronic diseases.

According to the European Commission report of 2019, around 58 percent of Germans, 65 and older, suffered from at least one chronic illness in 2017, a percentage that is slightly higher than that of other European nations.

Retractable needle safety syringes are being preferred for administering medicines to treat various chronic diseases. This might continue to propel sales of retractable needle safety syringes in the country during the assessment period.

How is the Retractable Needle Safety Syringes Market Expected to Fare in China?

Increasing Healthcare Spending Favoring Market Growth in China

Country China
Forecast CAGR % (2023 to 2033) 4.3%

China held around 41.1% value share in the East Asia retractable needle safety syringes market in 2022 and is projected to expand at a steady pace. Moreover, this growth is associated with rising healthcare expenditure, a notably growing geriatric population, and significantly improving medical infrastructure.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which is the Top Selling Product in the Retractable Needle Safety Syringes Market?

Sales of Manual Retractable Safety Syringes to Outperform Automatic Ones

Segment Manual Retractable Safety Syringe
Market Share % (2022) 62.13%

Manual retractable safety syringes currently hold a market share of around 62.13% in the global retractable needle safety syringes industry and this trend is likely to continue during the forecast period. This can be attributed to the rising usage of manual retractable safety syringes across healthcare facilities.

After administering the injection, the user of a manual retractable safety syringe can retract the needle either before or after extracting it from the patient.

Which is the Most Significant Application of Retractable Needle Safety Syringes?

Intravenous Segment is to Contribute most to the Global Retractable Needle Safety Syringes Market

Segment Intravenous
Market Share % (2022) 44.99%

The intravenous segment held a revenue share of 44.99% of the global retractable needle safety syringes market in 2022 and it is poised to expand at a relatively higher CAGR during the forecast period.

The high market share is because, with intravenous (IV) injection, the medication penetrates the systemic circulation directly, avoiding the first-pass drug effect and producing an instantaneous drug effect.

Which End User Segment Dominates the Global Retractable Needle Safety Syringes?

The Majority of Retractable Needle Safety Syringe Sales Remain Concentrated in Hospitals

As per FMI, the hospitals segment leads the global retractable needle safety syringes market with around 38.7%. This is attributable to the rising number of patients seeking treatments in hospitals and the surge in hospital-acquired infections.

Today, majority of the hospitals use retractable needle safety syringes due to their safe and hygienic nature. Further, the adoption of these syringes helps hospitals to curb the transmission of diseases due to needle stick injuries.

Which Distribution Channel Benefits the Retractable Needle Safety Syringes Market?

End Users Prefer to Purchase Retractable Needle Safety Syringes through Direct to Customer Channel

The direct to customer distribution channel leads the retractable needle safety syringes market with around 89.3% market share. It is because the direct-to-consumer distribution channel involves selling goods directly to clients rather than through wholesalers, retailers, or other middlemen.

Competitive Landscape

Key players in the retractable needle safety syringes market are continuously adopting various organic and inorganic strategies such as acquisitions, partnerships, mergers, new product launches, and geographical expansion to increase their revenue share and gain an upper hand in the market.

Given below are a few examples of the key strategies followed by the manufacturers:

  • In February 2022, BD completed the acquisition of Cytognos, operating in blood cancer diagnosis, immune monitoring research for blood diseases, and minimal residual disease (MRD) detection.
  • In 2021, Datwyler and Roncadelle developed a new safety syringe with a needle retraction mechanism to eliminate needlestick injuries.
  • In May 2021, Retractable Technologies, Inc., under a technology investment agreement, received further funding from the United States government.

New startups are entering the safety syringes business amid increasing opportunities in retractable needle safety syringes space. Also, they are embracing innovation to introduce novel products that could potentially eliminate the risk of needle stick injuries.

Report Scope as per Retractable Needle Safety Syringes Industry Analysis

Attributes Details
Base Market Value (2022) US$ 5,846.6 million
Projected Market Size (2033) US$ 8,770.0 million
Growth Rate (2023 to 2033) 4.1%
Forecast Period 2018 to 2022
Historical Data Available for 2023 to 2033
Market Analysis US$ million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered The United States, Canada, Brazil, Mexico, Argentina, Germany, The United Kingdom, France, Italy, Spain, BENELUX, Russia, Nordic Countries India, Indonesia, Malaysia, Philippines, Thailand, Vietnam, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, Israel, North Africa, and South Africa
Key Market Segments Covered Product, Application, End User, Distribution Channel, and Region
Key Companies Profiled
  • Axel Bio Corporation, Inc
  • Becton, Dickinson, and Company
  • Numedico
  • Lifelong Group
  • DMC Medical Ltd.
  • Retractable Technologies, Inc.
  • Smiths Medical
  • Sol-Millennium Medical Group
  • UltiMed, Inc. (Ulticare)
  • Revolutions Medical Corporation
  • Medicina (HMC Group)
  • Haiou Medical
  • Mediprim
  • Cardinal Health
  • Medline Industries
  • Duopross Meditech Corp.
  • Nipro Corporation
  • Terumo Corporation
Pricing Available upon Request

Key Market Segments Covered in Retractable Needle Safety Syringes Industry Research

By Product:

  • Manual Retractable Safety Syringe
  • Auto-retractable Safety Syringe

By Application:

  • Subcutaneous
  • Intramuscular
  • Intravenous

By End-User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Distribution Channel:

  • Direct to Customer
  • Retail
    • Retail Pharmacies
    • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Projected Size of the Market by 2033?

The global market size is to reach US$ 8,770 million by 2033.

Who are the key players in the Retractable Needle Safety Syringes Market?

Numedico, Lifelong Group, and DMC Medical Ltd. are key players in the market.

What is the Competitive Market Strategy for Key Players?

Key players are adopting various organic and inorganic strategies, such as acquisitions and partnerships.

Which Countries Dominate the Global Market?

The United States, Japan, and China dominate the global market.

Which is the Top Selling Product in the Retractable Needle Safety Syringes Market?

Manual retractable safety syringes are the top-selling product in the market.

How did the Retractable Needle Safety Syringes Market Fare in the United States?

The United States held 81.4% of North America’s retractable needle safety syringes market 2022.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
        5.3.1. Manual Retractable Safety Syringe
        5.3.2. Auto-retractable Safety Syringe
    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
        6.3.1. Subcutaneous
        6.3.2. Intramuscular
        6.3.3. Intravenous
    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033
        7.3.1. Hospitals
        7.3.2. Clinics
        7.3.3. Ambulatory Surgical Centres
        7.3.4. Others
    7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2018 to 2022
    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2023 to 2033
        8.3.1. Direct to Customer
        8.3.2. Retail
            8.3.2.1. Retail Pharmacies
            8.3.2.2. Drug Stores
        8.3.3. Online Pharmacies
    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Western Europe
        9.3.4. Eastern Europe
        9.3.5. South Asia and Pacific
        9.3.6. East Asia
        9.3.7. Middle East and Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. USA
            10.2.1.2. Canada
        10.2.2. By Product
        10.2.3. By Application
        10.2.4. By End-User
        10.2.5. By Distribution Channel
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product
        10.3.3. By Application
        10.3.4. By End-User
        10.3.5. By Distribution Channel
    10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Product
        11.2.3. By Application
        11.2.4. By End-User
        11.2.5. By Distribution Channel
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By Application
        11.3.4. By End-User
        11.3.5. By Distribution Channel
    11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. UK
            12.2.1.3. France
            12.2.1.4. Spain
            12.2.1.5. Italy
            12.2.1.6. Rest of Western Europe
        12.2.2. By Product
        12.2.3. By Application
        12.2.4. By End-User
        12.2.5. By Distribution Channel
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Application
        12.3.4. By End-User
        12.3.5. By Distribution Channel
    12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. Poland
            13.2.1.2. Russia
            13.2.1.3. Czech Republic
            13.2.1.4. Romania
            13.2.1.5. Rest of Eastern Europe
        13.2.2. By Product
        13.2.3. By Application
        13.2.4. By End-User
        13.2.5. By Distribution Channel
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Application
        13.3.4. By End-User
        13.3.5. By Distribution Channel
    13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. India
            14.2.1.2. Bangladesh
            14.2.1.3. Australia
            14.2.1.4. New Zealand
            14.2.1.5. Rest of South Asia and Pacific
        14.2.2. By Product
        14.2.3. By Application
        14.2.4. By End-User
        14.2.5. By Distribution Channel
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Application
        14.3.4. By End-User
        14.3.5. By Distribution Channel
    14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. China
            15.2.1.2. Japan
            15.2.1.3. South Korea
        15.2.2. By Product
        15.2.3. By Application
        15.2.4. By End-User
        15.2.5. By Distribution Channel
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By Application
        15.3.4. By End-User
        15.3.5. By Distribution Channel
    15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        16.2.1. By Country
            16.2.1.1. GCC Countries
            16.2.1.2. South Africa
            16.2.1.3. Israel
            16.2.1.4. Rest of MEA
        16.2.2. By Product
        16.2.3. By Application
        16.2.4. By End-User
        16.2.5. By Distribution Channel
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Product
        16.3.3. By Application
        16.3.4. By End-User
        16.3.5. By Distribution Channel
    16.4. Key Takeaways
17. Key Countries Market Analysis
    17.1. USA
        17.1.1. Pricing Analysis
        17.1.2. Market Share Analysis, 2022
            17.1.2.1. By Product
            17.1.2.2. By Application
            17.1.2.3. By End-User
            17.1.2.4. By Distribution Channel
    17.2. Canada
        17.2.1. Pricing Analysis
        17.2.2. Market Share Analysis, 2022
            17.2.2.1. By Product
            17.2.2.2. By Application
            17.2.2.3. By End-User
            17.2.2.4. By Distribution Channel
    17.3. Brazil
        17.3.1. Pricing Analysis
        17.3.2. Market Share Analysis, 2022
            17.3.2.1. By Product
            17.3.2.2. By Application
            17.3.2.3. By End-User
            17.3.2.4. By Distribution Channel
    17.4. Mexico
        17.4.1. Pricing Analysis
        17.4.2. Market Share Analysis, 2022
            17.4.2.1. By Product
            17.4.2.2. By Application
            17.4.2.3. By End-User
            17.4.2.4. By Distribution Channel
    17.5. Germany
        17.5.1. Pricing Analysis
        17.5.2. Market Share Analysis, 2022
            17.5.2.1. By Product
            17.5.2.2. By Application
            17.5.2.3. By End-User
            17.5.2.4. By Distribution Channel
    17.6. UK
        17.6.1. Pricing Analysis
        17.6.2. Market Share Analysis, 2022
            17.6.2.1. By Product
            17.6.2.2. By Application
            17.6.2.3. By End-User
            17.6.2.4. By Distribution Channel
    17.7. France
        17.7.1. Pricing Analysis
        17.7.2. Market Share Analysis, 2022
            17.7.2.1. By Product
            17.7.2.2. By Application
            17.7.2.3. By End-User
            17.7.2.4. By Distribution Channel
    17.8. Spain
        17.8.1. Pricing Analysis
        17.8.2. Market Share Analysis, 2022
            17.8.2.1. By Product
            17.8.2.2. By Application
            17.8.2.3. By End-User
            17.8.2.4. By Distribution Channel
    17.9. Italy
        17.9.1. Pricing Analysis
        17.9.2. Market Share Analysis, 2022
            17.9.2.1. By Product
            17.9.2.2. By Application
            17.9.2.3. By End-User
            17.9.2.4. By Distribution Channel
    17.10. Poland
        17.10.1. Pricing Analysis
        17.10.2. Market Share Analysis, 2022
            17.10.2.1. By Product
            17.10.2.2. By Application
            17.10.2.3. By End-User
            17.10.2.4. By Distribution Channel
    17.11. Russia
        17.11.1. Pricing Analysis
        17.11.2. Market Share Analysis, 2022
            17.11.2.1. By Product
            17.11.2.2. By Application
            17.11.2.3. By End-User
            17.11.2.4. By Distribution Channel
    17.12. Czech Republic
        17.12.1. Pricing Analysis
        17.12.2. Market Share Analysis, 2022
            17.12.2.1. By Product
            17.12.2.2. By Application
            17.12.2.3. By End-User
            17.12.2.4. By Distribution Channel
    17.13. Romania
        17.13.1. Pricing Analysis
        17.13.2. Market Share Analysis, 2022
            17.13.2.1. By Product
            17.13.2.2. By Application
            17.13.2.3. By End-User
            17.13.2.4. By Distribution Channel
    17.14. India
        17.14.1. Pricing Analysis
        17.14.2. Market Share Analysis, 2022
            17.14.2.1. By Product
            17.14.2.2. By Application
            17.14.2.3. By End-User
            17.14.2.4. By Distribution Channel
    17.15. Bangladesh
        17.15.1. Pricing Analysis
        17.15.2. Market Share Analysis, 2022
            17.15.2.1. By Product
            17.15.2.2. By Application
            17.15.2.3. By End-User
            17.15.2.4. By Distribution Channel
    17.16. Australia
        17.16.1. Pricing Analysis
        17.16.2. Market Share Analysis, 2022
            17.16.2.1. By Product
            17.16.2.2. By Application
            17.16.2.3. By End-User
            17.16.2.4. By Distribution Channel
    17.17. New Zealand
        17.17.1. Pricing Analysis
        17.17.2. Market Share Analysis, 2022
            17.17.2.1. By Product
            17.17.2.2. By Application
            17.17.2.3. By End-User
            17.17.2.4. By Distribution Channel
    17.18. China
        17.18.1. Pricing Analysis
        17.18.2. Market Share Analysis, 2022
            17.18.2.1. By Product
            17.18.2.2. By Application
            17.18.2.3. By End-User
            17.18.2.4. By Distribution Channel
    17.19. Japan
        17.19.1. Pricing Analysis
        17.19.2. Market Share Analysis, 2022
            17.19.2.1. By Product
            17.19.2.2. By Application
            17.19.2.3. By End-User
            17.19.2.4. By Distribution Channel
    17.20. South Korea
        17.20.1. Pricing Analysis
        17.20.2. Market Share Analysis, 2022
            17.20.2.1. By Product
            17.20.2.2. By Application
            17.20.2.3. By End-User
            17.20.2.4. By Distribution Channel
    17.21. GCC Countries
        17.21.1. Pricing Analysis
        17.21.2. Market Share Analysis, 2022
            17.21.2.1. By Product
            17.21.2.2. By Application
            17.21.2.3. By End-User
            17.21.2.4. By Distribution Channel
    17.22. South Africa
        17.22.1. Pricing Analysis
        17.22.2. Market Share Analysis, 2022
            17.22.2.1. By Product
            17.22.2.2. By Application
            17.22.2.3. By End-User
            17.22.2.4. By Distribution Channel
    17.23. Israel
        17.23.1. Pricing Analysis
        17.23.2. Market Share Analysis, 2022
            17.23.2.1. By Product
            17.23.2.2. By Application
            17.23.2.3. By End-User
            17.23.2.4. By Distribution Channel
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Product
        18.3.3. By Application
        18.3.4. By End-User
        18.3.5. By Distribution Channel
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Axel Bio Corporation, Inc
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
                19.1.1.5.2. Product Strategy
                19.1.1.5.3. Channel Strategy
        19.1.2. Becton, Dickinson and Company
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
                19.1.2.5.2. Product Strategy
                19.1.2.5.3. Channel Strategy
        19.1.3. Numedico
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
                19.1.3.5.2. Product Strategy
                19.1.3.5.3. Channel Strategy
        19.1.4. Lifelong Group
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
                19.1.4.5.2. Product Strategy
                19.1.4.5.3. Channel Strategy
        19.1.5. DMC Medical Ltd.
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
                19.1.5.5.2. Product Strategy
                19.1.5.5.3. Channel Strategy
        19.1.6. Retractable Technologies, Inc.
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
                19.1.6.5.2. Product Strategy
                19.1.6.5.3. Channel Strategy
        19.1.7. Smiths Medical
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
                19.1.7.5.2. Product Strategy
                19.1.7.5.3. Channel Strategy
        19.1.8. Sol-Millennium Medical Group
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
                19.1.8.5.2. Product Strategy
                19.1.8.5.3. Channel Strategy
        19.1.9. UltiMed, Inc. (Ulticare)
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
                19.1.9.5.2. Product Strategy
                19.1.9.5.3. Channel Strategy
        19.1.10. Revolutions Medical Corporation
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
                19.1.10.5.2. Product Strategy
                19.1.10.5.3. Channel Strategy
        19.1.11. Medicina (HMC Group)
            19.1.11.1. Overview
            19.1.11.2. Product Portfolio
            19.1.11.3. Profitability by Market Segments
            19.1.11.4. Sales Footprint
            19.1.11.5. Strategy Overview
                19.1.11.5.1. Marketing Strategy
                19.1.11.5.2. Product Strategy
                19.1.11.5.3. Channel Strategy
        19.1.12. Haiou Medical
            19.1.12.1. Overview
            19.1.12.2. Product Portfolio
            19.1.12.3. Profitability by Market Segments
            19.1.12.4. Sales Footprint
            19.1.12.5. Strategy Overview
                19.1.12.5.1. Marketing Strategy
                19.1.12.5.2. Product Strategy
                19.1.12.5.3. Channel Strategy
        19.1.13. Mediprim
            19.1.13.1. Overview
            19.1.13.2. Product Portfolio
            19.1.13.3. Profitability by Market Segments
            19.1.13.4. Sales Footprint
            19.1.13.5. Strategy Overview
                19.1.13.5.1. Marketing Strategy
                19.1.13.5.2. Product Strategy
                19.1.13.5.3. Channel Strategy
        19.1.14. Cardinal Health
            19.1.14.1. Overview
            19.1.14.2. Product Portfolio
            19.1.14.3. Profitability by Market Segments
            19.1.14.4. Sales Footprint
            19.1.14.5. Strategy Overview
                19.1.14.5.1. Marketing Strategy
                19.1.14.5.2. Product Strategy
                19.1.14.5.3. Channel Strategy
        19.1.15. Medline Industries
            19.1.15.1. Overview
            19.1.15.2. Product Portfolio
            19.1.15.3. Profitability by Market Segments
            19.1.15.4. Sales Footprint
            19.1.15.5. Strategy Overview
                19.1.15.5.1. Marketing Strategy
                19.1.15.5.2. Product Strategy
                19.1.15.5.3. Channel Strategy
        19.1.16. Duopross Meditech Corp.
            19.1.16.1. Overview
            19.1.16.2. Product Portfolio
            19.1.16.3. Profitability by Market Segments
            19.1.16.4. Sales Footprint
            19.1.16.5. Strategy Overview
                19.1.16.5.1. Marketing Strategy
                19.1.16.5.2. Product Strategy
                19.1.16.5.3. Channel Strategy
        19.1.17. Nipro Corporation
            19.1.17.1. Overview
            19.1.17.2. Product Portfolio
            19.1.17.3. Profitability by Market Segments
            19.1.17.4. Sales Footprint
            19.1.17.5. Strategy Overview
                19.1.17.5.1. Marketing Strategy
                19.1.17.5.2. Product Strategy
                19.1.17.5.3. Channel Strategy
        19.1.18. Terumo Corporation
            19.1.18.1. Overview
            19.1.18.2. Product Portfolio
            19.1.18.3. Profitability by Market Segments
            19.1.18.4. Sales Footprint
            19.1.18.5. Strategy Overview
                19.1.18.5.1. Marketing Strategy
                19.1.18.5.2. Product Strategy
                19.1.18.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Recommendations

Packaging

Safety Box for Syringe Market

July 2022

REP-GB-9336

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Retractable Needle Safety Syringes Market

Schedule a Call